In what could be a landmark case, six patients in California are suing one of the world’s largest stem-cell companies for allegedly misleading them about the effectiveness of its stem-cell treatments.
The six patients all live in Los Angeles or Orange County and share the last name Lee. Some of them are related, according to their lawyer, the unrelated Sang I Lee. They are suing Human Biostar based in Sugar Land, Texas; Jin Han Hong, the company’s chief operating officer; and Jeong Chan Ra, a Korean citizen and chairman of the board of Seoul-based RNL Bio, the parent company of Human Biostar.
Although the US Food and Drug Administration (FDA) and Federal Bureau of Investigation have taken action against stem-cell traders and clinicians, this seems to be the first case in which patients are bringing a suit against a prominent company. Whatever way this case goes, it will probably clue aggressive lawyers in to the mismatch between what stem-cell companies are promising and what they are delivering, says Bernard Siegel, director of Genetics Policy Institute, a...